AH
Alan L Heller
Director

Alan L Heller insider trades: Neos Therapeutics (NEOS) stock purchases

Director, Neos Therapeutics Last trade Nov 8, 2018 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2005
5
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Alan reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 8, 2018NEOS↑ Buy$100K
May 19, 2016NEOS↑ Buy$76K
Sep 15, 2011SVNT↑ Buy$30K
Sep 10, 2008APNS↑ Buy$3K
Sep 9, 2008APNS↑ Buy$2K
Dec 17, 2007APNS↑ Buy$7K
Nov 16, 2007APNS↑ Buy$8K
May 25, 2006SVNT↑ Buy$55K
May 18, 2005APPX↑ Buy$421K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Alan L Heller's insider trades

Alan L Heller is a director at Neos Therapeutics (NEOS). Since May 18, 2005, Alan has reported 9 open-market purchases worth $701K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (22 filings), shares returned to the company (1 filing), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEOS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.